INTRODUCTION
Testing the response to inhaled methacholine is useful in clinical settings for guiding asthma diagnostics (Cockcroft, 2010; Nair et al., 2017; O'Byrne, 2010). The test is conventionally measured by spirometry and, therefore, requires the patient to perform forceful breathing maneuvers throughout the methacholine challenge to track the changes in forced expiratory volume in 1 s (FEV1). Alternatively, the methacholine response can be measured by oscillometry (King et al., 2020), a technique currently spreading in clinical settings (Donohue & Kaminsky, 2024; Lundblad et al., 2021). Since oscillometry is effortless, it is often promoted for people unable to perform the forceful spirometric breathing maneuvers. These include children, the elderly, and patients for whom the forced maneuvers are contraindicated (Jordon et al., 2022). Yet, readouts collected by oscillometry are also very different from spirometry (Bossé, 2022). They also better disaggregate the contribution of large versus small airways (Chiu et al., 2020; Cottini et al., 2023). Spirometry and oscillometry are therefore complementary, and it would be worthwhile to use them together in all people during the methacholine challenge.
One inconvenience is that the measurement of FEV1 in spirometry requires forceful expiratory maneuvers starting from a full deep inspiration. While the dynamic compression of the forceful expiration does not seem to influence the methacholine response (West et al., 2012), the deep inspiration is known to attenuate it by causing a significant bronchodilation (Allen et al., 2008; Chapman et al., 2011; Duggan et al., 1990; Hida et al., 1984; Kapsali et al., 2000; King et al., 2001; Malmberg et al., 1993; Nadel & Tierney, 1961; Salerno et al., 2005; Scichilone et al., 2001; Skloot & Togias, 2003). Therefore, whether oscillometry should be used in conjunction with spirometry for methacholine testing in clinical settings remains uncertain. The crux lies in the extent to which the oscillometric readouts are influenced by the deep inspirations that are required in spirometry to monitor the response to methacholine, which is specifically addressed herein in asthmatic patients.
MATERIALS AND METHODS
All procedures were approved by the ethics committee of the IUCPQ (protocol 21,001) and all volunteers gave written informed consent. Patients were recruited from the staff and students of Université Laval. Only patients with an asthma severity classified at steps 1–3 of GINA guidelines (Global Initiative for Asthma, n.d.) were included. The other inclusion and exclusion criteria are described in a supplementary file.
Patients were enrolled from January to July 2024. All subjects attended three visits (visits 0, 1 and 2). Each visit was separated by at least 48 h, with an average of 9.3 ± 4.3 days. For medicated asthmatic patients, short- and long-acting β2-agonists were prohibited for at least 8 and 24 h, respectively, before each visit. Inhaled corticosteroids and leukotriene receptor antagonists were also prohibited before testing on each visit day. Baseline lung function measured by spirometry and respiratory mechanics measured by oscillometry were assessed at each visit. Owing to the waxing and waning nature of asthma, these baseline measurements were important to ascertain that the patients' basal states were on average similar and, therefore, unlikely to influence the differences in the methacholine response between visits. For these baseline measurements, spirometry was performed before oscillometry, but at least 10 min separated both techniques in order to avoid the bronchoprotective effect of deep inspirations (Allen et al., 2008; Chapman et al., 2011; Duggan et al., 1990; Hida et al., 1984; Kapsali et al., 2000; King et al., 2001; Malmberg et al., 1993; Nadel & Tierney, 1961; Salerno et al., 2005; Scichilone et al., 2001; Skloot & Togias, 2003). As an indirect index of eosinophilic inflammation, the fraction of exhaled nitric oxide (FeNO) was also measured on each visit.
Lung volumes, including total lung capacity (TLC), residual volume (RV) and functional residual capacity (FRC), were also measured at visit 0 by body plethysmography (Platinum Elite™ body plethysmograph with RTD, MGC Diagnostics Corporation, Saint Paul, MN). Predicted values for spirometric lung function and plethysmographic lung volumes were from Quanjer et al. (Quanjer et al., 2012) and Hall et al. (Hall et al., 2021), respectively.
Methacholine challenges were performed on visits 1 and 2 using the tidal breathing method (Coates et al., 2017). The procedures are detailed in Figure 1. Most procedures on visit 1 are consistent with current guidelines (Coates et al., 2017). The major difference is that oscillometry was also used to monitor the methacholine response (Figure 1). Oscillometry was performed as recommended by current guidelines (King et al., 2020). These oscillometric measurements also compelled us to extend the time interval between concentrations to 6 min, instead of the 5 min recommended in guidelines (Coates et al., 2017). Another difference with guidelines is that we are using concentrations instead of doses to report the methacholine response. Since this is an interventional study where the same subjects are tested twice, the use of concentrations instead of doses should not have affected the comparison between visits. Yet, it is acknowledged that different doses may have been delivered depending on the output of the nebulizer and the breathing pattern of the participants on each testing day. The methacholine test was stopped when: (1) the concentration of methacholine causing a 20% decline in FEV1 (PC20) was reached, which was determined in visit 1 but was also used as the final dose in visit 2; (2) the maximal concentration of 16 mg/mL was attained; or (3) the perception of dyspnea rose to 7/10 or above on the Borg scale.
[IMAGE OMITTED. SEE PDF]
The effect of spirometry on the oscillometric response to methacholine was assessed by comparing the maximal response between visits. Several oscillometric readouts were used to quantify this difference. They include: (1) resistance of the respiratory system at 5 Hz (Rrs5), an increase reflecting narrowing throughout the entire airway tree; (2) resistance of the respiratory system at 19 Hz (Rrs19), an increase reflecting large airway narrowing; (3) Rrs5 minus Rrs19 (Rrs5-19), an increase reflecting small airway narrowing and narrowing heterogeneity; and (4) three different indices of lung stiffness, namely reactance of the respiratory system at 5 Hz (Xrs5), resonant frequency (Fres), and reactance area (Ax), which respectively decrease, increase, and increase when the lung becomes stiffer due to tissue stiffening and/or airway closure.
The end-tidal expiratory lung volume (EELV) was also measured at the end of each methacholine challenge. This was done to assess the lung volume at which the subject was breathing at the end of the methacholine challenge and to detect the presence, and quantify the extent, of hyperinflation. More precisely, it was done at the very last oscillometric measurement (at the 5 min time-point in Figure 2b). After breathing at tidal volume for approximately 30 s, as per all the preceding oscillometric measurement time-points, the subjects were instructed to take a deep inspiration to TLC before leaving the oscillometric device. The volume trace, which was continuously recorded during the oscillometric measurement, thus contained a maximal point representing TLC. By referring this maximal point to TLC measured at visit 0 by plethysmography, it was possible to calculate the volume at which the subjects were breathing at any time during this last oscillometric measurement. This is valid assuming that TLC is relatively stable over time and not influenced by methacholine. The EELV was calculated by taking the volumes at the end of each tidal expiration and averaging them over the entire period of oscillometric measurement (i.e., ~30 s). Hyperinflation was subsequently calculated by subtracting FRC (measured on visit 0) from EELV, and is expressed in percentage of TLC.
[IMAGE OMITTED. SEE PDF]
Statistics
Paired t-tests were used to compare between the two visits. The methacholine response for all oscillometric and spirometric readouts was fitted to a second order polynomial. The curves were then used for interpolating the PC20. A Wilcoxon test was used to compare the number of doubling concentrations between visits. Statistical analyses were performed using Prism (version 10.4.0, GraphPad, San Diego, CA) and p < 0.05 was considered significant.
RESULTS
A total of 16 asthmatic patients were recruited, and all completed the study. Demographics and baseline characteristics are shown in Table 1. No significant differences were observed at baseline between visits 1 and 2 in terms of lung function (spirometry), respiratory mechanics (oscillometry), and inflammation (FeNO). The same final methacholine concentration was reached on both visits for all patients, except one. In the latter, the challenge was stopped prematurely in visit 2 (at 2 instead of 8 mg/mL of methacholine) because the dyspnea Borg score rose above 7/10.
TABLE 1 Demographics, as well as baseline lung function.
Sample size | 16 | ||
Sex (% female) | 75 | ||
Age (years) | 29.0 ± 14.5 | ||
Ethnicity | 16 Caucasians | ||
Number of ever smoker | 0 | ||
BMI (kg/m2) | 26.6 ± 5.1 | ||
Medication, number of patients | SABA | 11 | |
LABA | 6 | ||
ICSa | 12 | ||
LTRA | 0 | ||
TLC (L) | 6.2 ± 0.8 | ||
TLC (% of predicted value) | 107.9 ± 10.9 | ||
FRC (L) | 3.1 ± 0.5 | ||
FRC (% of predicted value) | 103.9 ± 11.3 | ||
RV (L) | 1.9 ± 0.5 | ||
RV (% of predicted value) | 118.0 ± 25.1 | ||
Visit 1 | Visit 2 | p value | |
FEV1 (L) | 3.4 ± 0.6 | 3.5 ± 0.5 | 0.37 |
FEV1 (% of predicted value) | 94.1 ± 13.5 | 96.2 ± 13.3 | 0.30 |
Rrs5 (cmH2O·s/L) | 3.9 ± 1.3 | 3.9 ± 1.3 | 0.75 |
Rrs19 (cmH2O·s/L) | 3.2 ± 0.6 | 3.2 ± 0.7 | 0.95 |
Rrs5-19 (cmH2O·s/L) | 0.7 ± 1.1 | 0.7 ± 0.9 | 0.59 |
Xrs5 (cmH2O·s/L) | −1.9 ± 1.3 | −1.7 ± 1.0 | 0.34 |
Fres (Hz) | 18.3 ± 8.9 | 18.8 ± 9.3 | 0.73 |
Ax (cmH2O/L) | 13.6 ± 18.8 | 12.8 ± 15.1 | 0.72 |
FeNO (ppb) | 22.2 ± 11.5 | 26.1 ± 15.6 | 0.15 |
Final methacholine concentration (mg/mL) | 3.2 ± 4.2 | 2.8 ± 4.0 | 0.33 |
The oscillometric results of a representative patient are depicted in Figure 2. The maximal response for each patient, the one after the final methacholine concentration, is depicted in Figure 3. The entire concentration-response, as in Figure 2, cannot be shown in groups because the patients were exposed to a different final concentration, as well as to a different number of concentrations. At 2.5 min after the beginning of nebulization of the final concentration, there were no differences in the oscillometric results between visits. However, at 5 min, the maximal response of all oscillometric readouts, except for Rrs19, was greater in visit 2 (without spirometry) than in visit 1 (with spirometry). The magnitude of the changes in oscillometric readouts caused by the final concentration of methacholine compared to baseline, as well as the percentage differences between visits are also shown in Table 2.
[IMAGE OMITTED. SEE PDF]
TABLE 2 Changes induced by methacholine between visits.
2.5 min | 5 min | |||||||
Visit 1 | Visit 2 | Delta (%)a | p value | Visit 1 | Visit 2 | Delta (%)a | p value | |
ΔRrs5 (cmH2O·s/L) |
2.6 ± 2.1 | 3.1 ± 2.0 | 18.9 | 0.29 | 2.0 ± 1.7 | 3.2 ± 2.1 | 55.9 | 0.012 |
ΔRrs19 (cmH2O·s/L) |
0.5 ± 0.6 | 0.5 ± 0.6 | 0.9 | 0.97 | 0.4 ± 0.4 | 0.6 ± 0.6 | 49.0 | 0.19 |
ΔRrs5-19 (cmH2O·s/L) |
2.1 ± 1.9 | 2.6 ± 1.7 | 23.2 | 0.24 | 1.6 ± 1.6 | 2.6 ± 1.7 | 57.5 | 0.018 |
ΔXrs5 (cmH2O·s/L) |
−2.9 ± 3.0 | −4.1 ± 3.2 | 41.9 | 0.14 | −2.1 ± 2.3 | −3.7 ± 2.7 | 75.8 | 0.025 |
ΔFres (Hz) |
14.6 ± 9.6 | 17.2 ± 9.2 | 17.6 | 0.31 | 12.3 ± 7.6 | 15.7 ± 9.3 | 28.1 | 0.16 |
ΔAx (cmH2O/L) |
44.3 ± 36.5 | 61.3 ± 45.2 | 38.5 | 0.10 | 33.9 ± 31.4 | 55.9 ± 42.8 | 65.0 | 0.018 |
The concentration of methacholine that was required to result in an equivalent change in Xrs5 between visits was then compared. For this comparison, the PC20 was used, except for three patients who did not reach the PC20. In the latter, the final concentration was used. This comparative concentration was on average 2.8 ± 4.2 mg/mL in visit 1 and did change Xrs5 by an average of 79.1 ± 54.2%. In order to reach the same average change in Xrs5 in visit 2, a concentration of 1.3 ± 2.0 mg/mL was required (p = 0.116). In terms of doubling concentrations, this change in Xrs5 was attained by 3.7 ± 1.8 doubling concentrations in visit 1 versus 2.8 ± 1.6 doubling concentrations in visit 2 (p = 0.0078). This means that an equivalent percentage increase in Xrs5 was attained with a lower number of doubling concentrations in visit 2 compared to visit 1. On an individual basis, the number of doubling concentrations to achieve the same change in Xrs5 would have changed by −3 in two patients, by −2 in two patients, by −1 in six patients, by 0 in five patients, and by +1 in one patient in visit 2 compared to visit 1.
Hyperinflation, the difference between EELV at the end of the methacholine challenge in visit 1 or 2 and FRC in visit 0 expressed in percentage of TLC, is depicted in Figure 4. One patient did not take the deep inspiration to TLC before leaving the device during the last oscillometric measurement in visit 2 (the operator forgot to repeat this instruction). As this deep inspiration was required to calculate the degree of hyperinflation, this patient was excluded from this analysis. Another patient was excluded because the last methacholine concentrations used in visit 1 were not tolerated in visit 2. This patient was excluded because the comparison of hyperinflation between visits is only valid if done at the same final concentration. The final sample size for this analysis was thus restricted to 14. The results demonstrate that hyperinflation was observed on both visits, but it was substantially greater in visit 2 than visit 1 (p < 0.0001). Note that two patients in visit 1 had a negative value of hyperinflation, meaning that they deflated (i.e., their EELV decreased) during the methacholine challenge.
[IMAGE OMITTED. SEE PDF]
DISCUSSION
No previous studies have directly compared the oscillometric response to methacholine with and without concomitant spirometry. This comparison has previously been called for (Donohue & Kaminsky, 2024), including in current guidelines (King et al., 2020). The present study demonstrated that the deep inspirations required in spirometry to track lung function during a methacholine challenge attenuate the oscillometric response.
Many investigators have evaluated the methacholine response by using both spirometry and oscillometry during the same challenge (Bailly et al., 2011; Broeders et al., 2005; Corral-Blanco et al., 2024; Jara-Gutierrez et al., 2019; Kim et al., 2009; Mansur et al., 2008; Naji et al., 2013; Nazemiyah et al., 2021; Petak et al., 2012; Schulze et al., 2012; Short et al., 2015; Urbankowski & Przybylowski, 2021; Vink et al., 2003; Yoon et al., 2014). Others have used oscillometry alone; i.e., without comparing it with the combined use of oscillometry and spirometry (Jee et al., 2010; Kalliola et al., 2014; Klug & Bisgaard, 1997). The results indicated that oscillometry is either equivalent or superior to monitoring the methacholine response or detecting hyperresponsiveness (i.e., a decline in FEV1 of more than 20% with a concentration of methacholine inferior to 4 mg/mL). Since oscillometry is less demanding for both the patient and the operator, these studies already suggested that oscillometry should be the technique of predilection for methacholine testing.
Some advantages of oscillometry may also be potentiated without concomitant spirometry. Indeed, excluding forceful breathing maneuvers should decrease the risk of exposure to airborne pathogens (and respiratory infections) for the operator and other health practitioners working at or near lung physiology labs (Gupta et al., 2021; Kouri et al., 2020; Lundblad & Chow, 2020). Oscillometry alone is also likely to decrease the concentration of methacholine needed to report a positive response, since deep inspirations, such as the ones required for measuring FEV1, attenuate the methacholine response (Allen et al., 2008; Chapman et al., 2011; Duggan et al., 1990; Hida et al., 1984; Kapsali et al., 2000; King et al., 2001; Malmberg et al., 1993; Nadel & Tierney, 1961; Salerno et al., 2005; Scichilone et al., 2001; Skloot & Togias, 2003). Although long suspected (Petak et al., 2012), this latter benefit had never been directly quantified before. Using oscillometry alone may also improve the diagnosis of asthma by increasing the number of positive test results, depending on the cut-offs chosen for the oscillometric readouts.
The present study was specifically designed to compare the oscillometric response to methacholine with or without concomitant spirometry in a group of very mild to mild asthmatics. The results demonstrated that omitting the spirometric measurements enhances, at least on average, the oscillometric response to methacholine, which confirms long-held suspicions (Petak et al., 2012). This was shown for all oscillometric readouts, except for Rrs19. It is worth mentioning that Rrs19 changed relatively less compared to the other oscillometric readouts (Table 2), probably due, at least in part in this study, to the low methacholine concentrations used with asthmatics. We have also previously demonstrated, in both healthy and asthmatic individuals, that the effect of methacholine during a serial challenge with incremental concentrations is cumulative for oscillometric readouts appraising the lung and small airways (Rrs5, Rrs5-19, Xrs5, Fres, Ax) but not for readouts appraising exclusively large airways (Rrs19) (Henry et al., 2023), which may also account for the lack of difference in Rrs19 between visits in the present study. Previous studies have also documented that large airways are less responsive to the bronchodilator effect of deep inspirations than small airways (Brown et al., 2001; Marchal et al., 2002), which may be another reason why the changes in Rrs19 were not different between visits.
Importantly, although an equivalent change in Xrs5 was attained with a lower number of doubling concentrations in visit 2 than visit 1 (p = 0.0078), this difference did not represent one doubling concentration. This means that the final concentration used, as well as the duration of the methacholine test, would only be reduced in a fraction of patients. The effect size reported in the present study is therefore not as pronounced as anticipated. In fact, there were no significant differences between visits at 2.5 min (Figure 3), corresponding to the time point after the final concentration before spirometric maneuvers. This means that all deep inspirations during the preceding concentrations did not influence the oscillometric response to the final concentration. Yet, it is also understood that at concentrations lower than the PC20, the response is oftentimes weak or nonexistent, which likely foreclosed the bronchodilator effect of deep inspirations and perhaps explains the lack of difference between visits up to that point. Another possibility contributing to both the difference at 5 min and the lack of difference at 2.5 min is that the deep inspirations used to monitor the response to the preceding doses may have enhanced the bronchodilator effect of the deep inspirations used to monitor the response to the final dose. Indeed, Crimi and coworkers have previously demonstrated that the bronchoprotective effect of a series of deep inspirations was related to the fact that it potentiates the bronchodilator effect of a subsequent deep inspiration (Crimi et al., 2002).
A striking, and more surprising, difference between visits was the level of hyperinflation achieved at the end of the methacholine challenge. Although hyperinflation during a methacholine challenge is a phenomenon understudied, it is consistently reported when investigated (Eddy et al., 2020; Geier et al., 2019; Henry et al., 2023; Smith et al., 2020). Herein, hyperinflation was observed on both visits but was greater in visit 2 (19.9 ± 9.2% of TLC) compared to visit 1 (11.5 ± 8.1% of TLC). This difference is substantial. For a patient with a TLC of 8 L who is normally breathing at an EELV (or FRC) of 4 L, for example, this would mean breathing at 5.6 L in visit 2 instead of 4.9 L in visit 1. It confirmed, once again, that the methacholine response was greater without spirometric measurements.
Hyperinflation is obviously an important confounding factor because respiratory mechanics, as well as the methacholine-induced changes in respiratory mechanics, are strongly related to lung volume (Briscoe & Dubois, 1958; Ding et al., 1987; Gobbi et al., 2024). In fact, increasing EELV in healthy volunteers exerts a greater attenuating effect on the methacholine response than increasing the dynamic swings in tidal volume (Gobbi et al., 2024). Breathing at a higher lung volume decreases resistance because it stretches the airways open, and it also typically decreases elastance (and therefore increases reactance) because it recruits small airways and volume. The greater hyperinflation in visit 2 may thus explain why the size of the reported effect was not as large as anticipated, or why there were still no differences between visits at 2.5 min after inhaling the final methacholine concentration.
Together, these suggest that the greater oscillometric response in visit 2 versus visit 1 may have been amplified if one had been controlling for lung volume. Since hyperinflation is unconscious, its blunting effect on the methacholine response will remain a limitation, probably carrying more weight in oscillometry than spirometry. Although not recommended in current guidelines (King et al., 2020), we suggest that a deep inspiration to TLC at the last oscillometric measurement (before leaving the mouthpiece) should be incorporated in routine testing, especially during a methacholine challenge, so that the volume at which the patient is breathing could at least be reported. Notably, experimental data on isolated bronchi also demonstrated that hyperinflation blunted the bronchodilator response to deep inspirations (Cairncross et al., 2018). Since hyperinflation was observed in visit 1, it may have diminished the differences between visits 1 and 2 and contributed to the small effect size reported in the present study.
Another reason why the effect size was small may be related to the studied population. Indeed, asthmatic patients are known to exhibit a weaker bronchodilator response to deep inspirations (Allen et al., 2008; Black et al., 2004; Burns et al., 1985; Fish et al., 1981; Jensen et al., 2001; Lim et al., 1987; Salome et al., 2003; Scichilone et al., 2001; Skloot et al., 1995; Slats et al., 2007; Wheatley et al., 1989), thereby explaining the small effect of spirometry on the oscillometric response in the present study. The differences between visits may have also been mitigated in asthmatic patients because of their faster rate of re-narrowing following the bronchodilation caused by the deep inspiration (Brown et al., 2001; Jackson et al., 2004; Jensen et al., 2001; Salome et al., 2003). It is also worth mentioning that the bronchodilator response to deep inspirations in asthma is related to disease severity (Allen et al., 2008). In fact, the response can even be inversed in more severe asthma cases, where a deep inspiration may cause a bronchoconstriction (Fish et al., 1977; Lim et al., 1989). The reported effect size in the present study may thus vary according to the population studied, being possibly greater in non-asthmatic individuals and possibly smaller, perhaps nonexistent, in more severe asthmatic patients. Other studies will be needed.
Conclusion
The oscillometric response to methacholine is significantly attenuated by concomitant spirometry. Using oscillometry alone also reduces the number of doubling concentrations needed to reach an equivalent response. Yet, because hyperinflation during the challenge is furthered in the absence of periodic forceful spirometric maneuvers starting from a full deep inspiration, the size of this effect is small. By no means would the results of the present study discourage the use of oscillometry and spirometry in the same challenge. However, if the two techniques are to be used individually in clinical settings, it is argued that oscillometry supplants spirometry for methacholine testing, not only for people unable to perform spirometry but for everyone. This is partially based on the results of the present study, showing that the impact on clinical outcome would be minimal and it would hasten the test for a significant proportion of patients by reducing the number of methacholine doses, but also because oscillometry is easier (requiring no forceful expiratory maneuver starting from a full deep inspiration) than spirometry.
AUTHOR CONTRIBUTIONS
YB had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. CH, MB, MÈB, and AC contributed substantially to the study design, data analysis, and interpretation, and the writing of the manuscript.
FUNDING INFORMATION
This research was funded by: The Canadian Institutes of Health Research (CIHR, 508356-202209PJT); and the Natural Sciences and Engineering Research Council of Canada (NSERC, RGPIN-2020-06355).
CONFLICT OF INTEREST STATEMENT
AC is holding or has previously received grants or contracts from AstraZeneca, Regeneron, and Glaxo SmithKline, has previously received consulting fees or honoraria from AstraZeneca, Sanofi, Glaxo SmithKline, Valeo, and Covis, and has also served on advisory boards for AstraZeneca and Sanofi. CH, MB, MÈB, and YB have no conflicts of interest.
DATA AVAILABILITY STATEMENT
The datasets used and analyzed during the current study are available from the corresponding author on reasonable request.
ETHICS STATEMENT
This study has obtained ethics approval from the Institut Universitaire de Cardiologie et de Pneumologie de Québec review board (protocol 21001), and all volunteers gave written informed consent.
DISCLAIMERS
The content of this manuscript is solely the authors' responsibility and does not necessarily represent the official views of the funding agencies and the Université Laval.
Allen, N. D., Davis, B. E., & Cockcroft, D. W. (2008). Correlation between airway inflammation and loss of deep‐inhalation bronchoprotection in asthma. Annals of Allergy, Asthma & Immunology, 101, 413–418.
Bailly, C., Crenesse, D., & Albertini, M. (2011). Evaluation of impulse oscillometry during bronchial challenge testing in children. Pediatric Pulmonology, 46, 1209–1214.
Black, L. D., Henderson, A. C., Atileh, H., Israel, E., Ingenito, E. P., & Lutchen, K. R. (2004). Relating maximum airway dilation and subsequent reconstriction to reactivity in human lungs. Journal of Applied Physiology, 96, 1808–1814.
Bossé, Y. (2022). Understanding the fundamentals of oscillometry from a strip of lung tissue. Frontiers in Physiology, 13, 1–7.
Briscoe, W. A., & Dubois, A. B. (1958). The relationship between airway resistance, airway conductance and lung volume in subjects of different age and body size. The Journal of Clinical Investigation, 37, 1279–1285.
Broeders, M. E., Molema, J., Hop, W. C., & Folgering, H. T. (2005). Bronchial challenge, assessed with forced expiratory manoeuvres and airway impedance. Respiration Medicine, 99, 1046–1052.
Brown, R. H., Scichilone, N., Mudge, B., Diemer, F. B., Permutt, S., & Togias, A. (2001). High‐resolution computed tomographic evaluation of airway distensibility and the effects of lung inflation on airway caliber in healthy subjects and individuals with asthma. American Journal of Respiratory and Critical Care Medicine, 163(4), 994–1001. https://doi.org/10.1164/ajrccm.163.4.2007119
Burns, C. B., Taylor, W. R., & Ingram, R. H., Jr. (1985). Effects of deep inhalation in asthma: Relative airway and parenchymal hysteresis. Journal of Applied Physiology, 59, 1590–1596.
Cairncross, A., Noble, P. B., & McFawn, P. K. (2018). Hyperinflation of bronchi in vitro impairs bronchodilation to simulated breathing and increases sensitivity to contractile activation. Respirology, 23, 750–755.
Chapman, D. G., Brown, N. J., & Salome, C. M. (2011). The dynamic face of respiratory research: Understanding the effect of airway disease on a lung in constant motion. Pulmonary Pharmacology & Therapeutics, 24, 505–512.
Chiu, H. Y., Hsiao, Y. H., Su, K. C., Lee, Y. C., Ko, H. K., & Perng, D. W. (2020). Small airway dysfunction by impulse Oscillometry in symptomatic patients with preserved pulmonary function. The Journal of Allergy and Clinical Immunology: In Practice, 8, 229–235.e3.
Coates, A. L., Wanger, J., Cockcroft, D. W., Culver, B. H., Bronchoprovocation Testing Task Force, Kai‐Hakon, C., Diamant, Z., Gauvreau, G., Hall, G. L., Hallstrand, T. S., Horvath, I., de Jongh, F. H. C., Joos, G., Kaminsky, D. A., Laube, B. L., Leuppi, J. D., & Sterk, P. J. (2017). ERS technical standard on bronchial challenge testing: General considerations and performance of methacholine challenge tests. European Respiratory Journal, 49(5), 1601526.
Cockcroft, D. W. (2010). Direct challenge tests: Airway hyperresponsiveness in asthma: Its measurement and clinical significance. Chest, 138(2 Suppl), 18S‐24S.
Corral‐Blanco, M., Diaz Campos, R. M., Pelaez, A., & Melero Moreno, C. (2024). Beyond forced exhalation: Impulse oscillometry as a promising tool for bronchial hyperresponsiveness evaluation. Journal of Asthma, 61(5), 427–435. https://doi.org/10.1080/02770903.2023.2288316
Cottini, M., Bondi, B., Bagnasco, D., Braido, F., Passalacqua, G., Licini, A., Lombardi, C., Berti, A., Comberiati, P., Landi, M., Heffler, E., & Paoletti, G. (2023). Impulse oscillometry defined small airway dysfunction in asthmatic patients with normal spirometry: Prevalence, clinical associations, and impact on asthma control. Respiratory Medicine, 218, 107391.
Crimi, E., Pellegrino, R., Milanese, M., & Brusasco, V. (2002). Deep breaths, methacholine, and airway narrowing in healthy and mild asthmatic subjects. Journal of Applied Physiology, 93, 1384–1390.
Ding, D. J., Martin, J. G., & Macklem, P. T. (1987). Effects of lung volume on maximal methacholine‐induced bronchoconstriction in normal humans. Journal of Applied Physiology, 62, 1324–1330.
Donohue, P. A., & Kaminsky, D. A. (2024). The role of oscillometry in asthma. Current Opinion in Pulmonary Medicine, 30, 268–275.
Duggan, C. J., Chan, J., Whelan, A. J., & Berend, N. (1990). Bronchodilatation induced by deep breaths in relation to transpulmonary pressure and lung volume. Thorax, 45, 930–934.
Eddy, R. L., Svenningsen, S., Kirby, M., Knipping, D., McCormack, D. G., Licskai, C., Nair, P., & Parraga, G. (2020). Is computed tomography airway count related to asthma severity and airway structure and function? American Journal of Respiratory and Critical Care Medicine, 201, 923–933.
Fish, J. E., Ankin, M. G., Kelly, J. F., & Peterman, V. I. (1981). Regulation of bronchomotor tone by lung inflation in asthmatic and nonasthmatic subjects. Journal of Applied Physiology, 50, 1079–1086.
Fish, J. E., Peterman, V. I., & Cugell, D. W. (1977). Effect of deep inspiration on airway conductance in subjects with allergic rhinitis and allergic asthma. The Journal of Allergy and Clinical Immunology, 60, 41–46.
Geier, E. T., Theilmann, R. J., Prisk, G. K., & Sa, R. C. (2019). Regional airflow obstruction after bronchoconstriction and subsequent bronchodilation in subjects without pulmonary disease. Journal of Applied Physiology, 127, 31–39.
Global Initiative for Asthma. (n.d.). Global strategy for asthma management and prevention, 2021. https://www.ginasthma.org/reports
Gobbi, A., Antonelli, A., Dellaca, R., Pellegrino, G. M., Pellegrino, R., Fredberg, J. J., Solway, J., & Brusasco, V. (2024). Effects of increasing tidal volume and end‐expiratory lung volume on induced bronchoconstriction in healthy humans. Respiratory Research, 25, 298.
Gupta, N., Sachdev, A., & Gupta, D. (2021). Oscillometry‐a reasonable option to monitor lung functions in the era of COVID‐19 pandemic. Pediatric Pulmonology, 56, 14–15.
Hall, G. L., Filipow, N., Ruppel, G., Okitika, T., Thompson, B., Kirkby, J., Steenbruggen, I., Cooper, B. G., Stanojevic, S., & contributing GLINm. (2021). Official ERS technical standard: Global Lung function initiative reference values for static lung volumes in individuals of European ancestry. European Respiratory Journal, 57(3), 2000289. https://doi.org/10.1183/13993003.00289‐2020
Henry, C., Boucher, M., Boulay, M. E., Cote, A., Boulet, L. P., & Bosse, Y. (2023). The cumulative effect of methacholine on large and small airways when deep inspirations are avoided. Respirology, 28, 226–235.
Hida, W., Arai, M., Shindoh, C., Liu, Y. N., Sasaki, H., & Takishima, T. (1984). Effect of inspiratory flow rate on bronchomotor tone in normal and asthmatic subjects. Thorax, 39, 86–92.
Jackson, A. C., Murphy, M. M., Rassulo, J., Celli, B. R., & Ingram, R. H., Jr. (2004). Deep breath reversal and exponential return of methacholine‐induced obstruction in asthmatic and nonasthmatic subjects. Journal of Applied Physiology, 96, 137–142.
Jara‐Gutierrez, P., Aguado, E., Del Potro, M. G., Fernandez‐Nieto, M., Mahillo, I., & Sastre, J. (2019). Comparison of impulse oscillometry and spirometry for detection of airway hyperresponsiveness to methacholine, mannitol, and eucapnic voluntary hyperventilation in children. Pediatric Pulmonology, 54, 1162–1172.
Jee, H. M., Kwak, J. H., Jung, D. W., & Han, M. Y. (2010). Useful parameters of bronchial hyperresponsiveness measured with an impulse oscillation technique in preschool children. The Journal of Asthma, 47, 227–232.
Jensen, A., Atileh, H., Suki, B., Ingenito, E. P., & Lutchen, K. R. (2001). Selected contribution: Airway caliber in healthy and asthmatic subjects: Effects of bronchial challenge and deep inspirations. Journal of Applied Physiology, 91, 506–515; discussion 504–505.
Jordon, L. H., Gore, R. B., Rusk, R. A., Knox‐Brown, B., & Marciniak, S. J. (2022). The role of impulse oscillometry in the management of asthma when forced expiratory maneuvers are contraindicated: Case series and literature review. The Journal of Asthma, 59, 1577–1583.
Kalliola, S., Malmberg, L. P., Kajosaari, M., Mattila, P. S., Pelkonen, A. S., & Makela, M. J. (2014). Assessing direct and indirect airway hyperresponsiveness in children using impulse oscillometry. Annals of Allergy, Asthma & Immunology, 113, 166–172.
Kapsali, T., Permutt, S., Laube, B., Scichilone, N., & Togias, A. (2000). Potent bronchoprotective effect of deep inspiration and its absence in asthma. Journal of Applied Physiology, 89, 711–720.
Kim, H. Y., Shin, Y. H., Jung, D. W., Jee, H. M., Park, H. W., & Han, M. Y. (2009). Resistance and reactance in oscillation lung function reflect basal lung function and bronchial hyperresponsiveness respectively. Respirology, 14, 1035–1041.
King, G. G., Bates, J., Berger, K. I., Calverley, P., de Melo, P. L., Dellaca, R. L., Farre, R., Hall, G. L., Ioan, I., Irvin, C. G., Kaczka, D. W., Kaminsky, D. A., Kurosawa, H., Lombardi, E., Maksym, G. N., Marchal, F., Oppenheimer, B. W., Simpson, S. J., Thamrin, C., … Oostveen, E. (2020). Technical standards for respiratory oscillometry. The European Respiratory Journal, 55, 1900753.
King, G. G., Moore, B. J., Seow, C. Y., & Pare, P. D. (2001). Airway narrowing associated with inhibition of deep inspiration during methacholine inhalation in asthmatics. American Journal of Respiratory and Critical Care Medicine, 164, 216–218.
Klug, B., & Bisgaard, H. (1997). Repeatability of methacholine challenges in 2‐ to 4‐year‐old children with asthma, using a new technique for quantitative delivery of aerosol. Pediatric Pulmonology, 23, 278–286.
Kouri, A., Gupta, S., Yadollahi, A., Ryan, C. M., Gershon, A. S., To, T., Tarlo, S. M., Goldstein, R. S., Chapman, K. R., & Chow, C. W. (2020). Addressing reduced laboratory‐based pulmonary function testing during a pandemic. Chest, 158, 2502–2510.
Lim, T. K., Ang, S. M., Rossing, T. H., Ingenito, E. P., & Ingram, R. H., Jr. (1989). The effects of deep inhalation on maximal expiratory flow during intensive treatment of spontaneous asthmatic episodes. The American Review of Respiratory Disease, 140, 340–343.
Lim, T. K., Pride, N. B., & Ingram, R. H., Jr. (1987). Effects of volume history during spontaneous and acutely induced air‐flow obstruction in asthma. American Review of Respiratory Disease, 135(3), 591–596. https://doi.org/10.1164/arrd.1987.135.3.591
Lundblad, L. K. A., & Chow, C. W. (2020). Lung function monitoring in the era of respiratory pandemics. Clinical Physiology and Functional Imaging, 40, 377–379.
Lundblad, L. K. A., Siddiqui, S., Bossé, Y., & Dandurand, R. (2021). Applications of oscillometry in clinical research and practice. Canadian Journal of Respiratory, Critical Care, and Sleep Medicine, 5, 54–68.
Malmberg, P., Larsson, K., Sundblad, B. M., & Zhiping, W. (1993). Importance of the time interval between FEV1 measurements in a methacholine provocation test. The European Respiratory Journal, 6, 680–686.
Mansur, A. H., Manney, S., & Ayres, J. G. (2008). Methacholine‐induced asthma symptoms correlate with impulse oscillometry but not spirometry. Respiratory Medicine, 102, 42–49.
Marchal, F., Schweitzer, C., & Moreau‐Colson, C. (2002). Respiratory impedance response to a deep inhalation in children with history of cough or asthma. Pediatric Pulmonology, 33, 411–418.
Nadel, J. A., & Tierney, D. F. (1961). Effect of a previous deep inspiration on airway resistance in man. Journal of Applied Physiology, 16, 717–719.
Nair, P., Martin, J. G., Cockcroft, D. C., Dolovich, M., Lemiere, C., Boulet, L. P., & O'Byrne, P. M. (2017). Airway hyperresponsiveness in asthma: Measurement and clinical relevance. The Journal of Allergy and Clinical Immunology: In Practice, 5, 649–659.e2.
Naji, N., Keung, E., Kane, J., Watson, R. M., Killian, K. J., & Gauvreau, G. M. (2013). Comparison of changes in lung function measured by plethymography and IOS after bronchoprovocation. Respiratory Medicine, 107, 503–510.
Nazemiyah, M., Ansarin, K., Nouri‐Vaskeh, M., Sadegi, T., & Sharifi, A. (2021). Comparison of spirometry and impulse oscillometry in methacholine challenge test for the detection of airway hyperresponsiveness in adults. Tüberküloz ve Toraks, 69, 1–8.
O'Byrne, P. M. (2010). Introduction: Airway hyperresponsiveness in asthma: Its measurement and clinical significance. Chest, 138(2 Suppl), 1S–3S. https://doi.org/10.1378/chest.10‐0091
Petak, F., Czovek, D., & Novak, Z. (2012). Spirometry and forced oscillations in the detection of airway hyperreactivity in asthmatic children. Pediatric Pulmonology, 47, 956–965.
Quanjer, P. H., Stanojevic, S., Cole, T. J., Baur, X., Hall, G. L., Culver, B. H., Enright, P. L., Hankinson, J. L., Ip, M. S., Zheng, J., Stocks, J., & Initiative ERSGLF. (2012). Multi‐ethnic reference values for spirometry for the 3‐95‐yr age range: The global lung function 2012 equations. European Respiratory Journal, 40(6), 1324–1343. https://doi.org/10.1183/09031936.00080312
Salerno, F. G., Pellegrino, R., Trocchio, G., Spanevello, A., Brusasco, V., & Crimi, E. (2005). Attenuation of induced bronchoconstriction in healthy subjects: Effects of breathing depth. Journal of Applied Physiology, 98, 817–821.
Salome, C. M., Thorpe, C. W., Diba, C., Brown, N. J., Berend, N., & King, G. G. (2003). Airway re‐narrowing following deep inspiration in asthmatic and nonasthmatic subjects. The European Respiratory Journal, 22, 62–68.
Schulze, J., Smith, H. J., Fuchs, J., Herrmann, E., Dressler, M., Rose, M. A., & Zielen, S. (2012). Methacholine challenge in young children as evaluated by spirometry and impulse oscillometry. Respiratory Medicine, 106, 627–634.
Scichilone, N., Permutt, S., & Togias, A. (2001). The lack of the bronchoprotective and not the bronchodilatory ability of deep inspiration is associated with airway hyperresponsiveness. American Journal of Respiratory and Critical Care Medicine, 163, 413–419.
Short, P. M., Anderson, W. J., Manoharan, A., & Lipworth, B. J. (2015). Usefulness of impulse oscillometry for the assessment of airway hyperresponsiveness in mild‐to‐moderate adult asthma. Annals of Allergy, Asthma & Immunology, 115, 17–20.
Skloot, G., Permutt, S., & Togias, A. (1995). Airway hyperresponsiveness in asthma: A problem of limited smooth muscle relaxation with inspiration. The Journal of Clinical Investigation, 96, 2393–2403.
Skloot, G., & Togias, A. (2003). Bronchodilation and bronchoprotection by deep inspiration and their relationship to bronchial hyperresponsiveness. Clinical Reviews in Allergy and Immunology, 24, 55–72.
Slats, A. M., Janssen, K., van Schadewijk, A., van der Plas, D. T., Schot, R., van den Aardweg, J. G., de Jongste, J. C., Hiemstra, P. S., Mauad, T., Rabe, K. F., & Sterk, P. J. (2007). Bronchial inflammation and airway responses to deep inspiration in asthma and chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine, 176, 121–128.
Smith, B. M., Kirby, M., Hoffman, E. A., Kronmal, R. A., Aaron, S. D., Allen, N. B., Bertoni, A., Coxson, H. O., Cooper, C., Couper, D. J., Criner, G., Dransfield, M. T., Han, M. K., Hansel, N. N., Jacobs, D. R., Jr., Kaufman, J. D., Lin, C. L., Manichaikul, A., Martinez, F. J., … Investigators S. (2020). Association of Dysanapsis with Chronic Obstructive Pulmonary Disease among Older Adults. JAMA, 323, 2268–2280.
Urbankowski, T., & Przybylowski, T. (2021). Methacholine challenge testing: Comparison of FEV(1) and airway resistance parameters. Respiratory Care, 66, 449–459.
Vink, G. R., Arets, H. G., van der Laag, J., & van der Ent, C. K. (2003). Impulse oscillometry: A measure for airway obstruction. Pediatric Pulmonology, 35(3), 214–219. https://doi.org/10.1002/ppul.10235
West, A. R., Needi, E. T., Mitchell, H. W., McFawn, P. K., & Noble, P. B. (2012). Airways dilate to simulated inspiratory but not expiratory manoeuvres. European Respiratory Journal, 40, 455–461.
Wheatley, J. R., Pare, P. D., & Engel, L. A. (1989). Reversibility of induced bronchoconstriction by deep inspiration in asthmatic and normal subjects. European Respiratory Journal, 2, 331–339.
Yoon, J. W., Shin, Y. H., Jee, H. M., Chang, S. J., Baek, J. H., Choi, S. H., Kim, H. Y., & Han, M. Y. (2014). Useful marker of oscillatory lung function in methacholine challenge test‐comparison of reactance and resistance with dose‐response slope. Pediatric Pulmonology, 49, 521–528.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
© 2025. This work is published under http://creativecommons.org/licenses/by/4.0/ (the "License"). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Abstract
Oscillometry is proposed as a complementary technique to spirometry for methacholine testing. Yet, before being prescribed in conjunction with spirometry, the extent by which the oscillometric readouts are influenced by spirometric maneuvers, especially the deep inspirations, will need to be determined. Herein, 16 very mild‐to‐mild asthmatics underwent two methacholine challenges on separate visits. On visit 1, the response was tracked by both oscillometry and spirometry, and the challenge was stopped at the provocative concentration causing a decline in forced expiratory volume in 1 s of at least 20%. The same concentration regimen was used on visit 2, but the response was tracked by oscillometry only. The results demonstrated that, except for resistance at 19 Hz, the changes in all oscillometric readouts were greater in the challenge without spirometry (
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer